ArticleInternational urology and nephrology2017
External validation of a nomogram including the computed tomography imaging score to predict indolent renal masses.
Article in International urology and nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess a nomogram including the computed tomography (CT) score and body mass index (BMI) that was constructed to predict indolent diseases in a cohort of patients with renal masses. MATERIALS AND
methodsThe data collected from patients undergoing partial nephrectomy (PN) or radical nephrectomy (RN) between January 2012 and September 2016 were analyzed. Two urologic surgeons and a radiologist reviewed the images to determine the CT score. Postoperative pathological assessment was performed to categorize renal masses as either indolent or aggressive. The BMI and CT scores were included in the nomogram to identify the risk of indolent disease. The performance of the novel model was assessed by using discrimination, calibration plots, and decision curve analysis (DCA).
resultsTwo hundred and two participants (with 202 masses) who underwent RN or PN were included; 37% of the masses were indolent. The predictive performances of the nomogram revealed areas under the curve of 0.866 for masses of all cases and 0.808 for cT1 masses without visible fat. DCA revealed that the nomogram was moderately clinically useful. The calibration plots showed a reasonable calibration and systematic overestimation of indolent disease based on nomogram predictions.
conclusionsThe CT score nomogram discriminated well between indolent and aggressive renal masses. The model had a reasonable calibration in our cohort for discriminating indolent from aggressive lesions. Further research to validate and assess the nomogram is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.